Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.47 |
| ▸ | MMP2 | P08253 | 1/20 | 0.47 |
| ▸ | MMP3 | P08254 | 1/20 | 0.47 |
| ▸ | MMP8 | P22894 | 1/20 | 0.47 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.43 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.43 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.43 |
| ▸ | SMPD1 | P17405 | 6/20 | 0.39 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.38 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.38 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.38 |
| ▸ | FDPS | P14324 | 1/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6679361 | 0.93 | LPAR3 (0.47) | MMP1MMP2MMP3MMP8LPAR3 | |
| SCHEMBL28355957 | 0.91 | LPAR3 (0.50) | LPAR3LPAR2LPAR1SMPD1S1PR2 | |
| SCHEMBL10874339 | 0.91 | LPAR3 (0.50) | LPAR3LPAR2LPAR1SMPD1S1PR2 | |
| SCHEMBL28304867 | 0.86 | FDPS (0.43) | MMP1MMP2MMP3MMP8LPAR3 | |
| SCHEMBL9193462 | 0.84 | MMP1 (0.41) | MMP1MMP2MMP3MMP8LPAR3 | |
| SCHEMBL2870085 | 0.81 | CYP3A4 (0.42) | MMP1MMP2MMP3MMP8LPAR3 | |
| SCHEMBL27744120 | 0.80 | MMP1 (0.45) | MMP1MMP2MMP3MMP8LPAR3 | |
| SCHEMBL7115233 | 0.78 | S1PR2 (0.48) | LPAR3LPAR2LPAR1SMPD1S1PR2 | |
| SCHEMBL4624904 | 0.77 | LPAR3 (0.43) | MMP1MMP2MMP3MMP8LPAR3 | |
| SCHEMBL14782468 | 0.77 | FDPS (0.36) | MMP1MMP2MMP3MMP8LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116046920-B | Flow matching formula for tilmicosin content measurement | 山东久隆信和药业有限公司 | 2023-06-27 | — | — | CN | claimed |
| CN-116046920-A | Flow matching formula for tilmicosin content measurement | 山东久隆信和药业有限公司 | 2023-05-02 | — | — | CN | claimed |
| CN-115974100-A | Method for green synthesis of SAPO-31 molecular sieve by solid phase crystallization | 黑龙江大学 | 2023-04-18 | — | — | CN | claimed |
| CN-110963944-B | Novel low-free TDI polyurethane curing agent containing fluorocarbon chains and preparation method thereof | 华南理工大学 | 2021-09-21 | — | — | CN | claimed |
| CN-112763632-A | Method for detecting related substances of tilmicosin enteric-coated preparation | 天津瑞普生物技术股份有限公司 | 2021-05-07 | — | — | CN | claimed |
| CN-110963944-A | Novel low-free TDI polyurethane curing agent containing fluorocarbon chains and preparation method thereof | 华南理工大学 | 2020-04-07 | — | — | CN | claimed |
| EP-0280461-A2 | Dobutamine salts | ELI LILLY AND COMPANY (US) | 1988-08-31 | — | — | EP | claimed |
| EP-2841109-B1 | PRODRUGS OF HYDROXYL-COMPRISING DRUGS | ASCENDIS PHARMA AS (DK) | 2026-04-15 | — | — | EP | disclosed |
| EP-3782649-B1 | BIODEGRADABLE POLYETHYLENE GLYCOL BASED WATER-INSOLUBLE HYDROGELS | ASCENDIS PHARMA AS (DK) | 2025-05-14 | — | — | EP | disclosed |
| CN-111281980-B | Water-soluble gamma-polyglutamic acid-tilmicosin compound and preparation method thereof | 芽米科技(广州)有限公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-114062520-B | HPLC analysis method for hydroxychloroquine sulfate and related substances thereof | 上海上药中西制药有限公司 | 2024-11-29 | — | — | CN | disclosed |
| CN-117598997-B | Tilmicosin-natural plant organic acid microcrystalline double salt powder preparation and preparation method and application thereof | 沈阳伟嘉生物技术有限公司 | 2024-08-06 | — | — | CN | disclosed |
| CN-117598997-A | Tilmicosin-natural plant organic acid microcrystalline double salt powder preparation and preparation method and application thereof | 沈阳伟嘉生物技术有限公司 | 2024-02-27 | — | — | CN | disclosed |
| US-4863797-A | Flame-retarded composite fiber | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1989-09-05 | — | — | US | disclosed |
| CN-88100990-A | Improving one's methods of dobutamine salt | — | 1988-09-07 | — | — | CN | disclosed |
| EP-0280461-A2 | Dobutamine salts | ELI LILLY AND COMPANY (US) | 1988-08-31 | — | — | EP | disclosed |
| EP-0183014-A2 | Flame-retarded fiber blend | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1986-06-04 | — | — | EP | disclosed |
| US-4031092-A | 1,3-Bis-(carboxy-phenylamino)-s-triazines | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1977-06-21 | — | — | US | disclosed |
| US-4030812-A | Lyotropic birefringent films | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1977-06-21 | — | — | US | disclosed |
| US-3970574-A | TRIETHYLENE GLYCOL DIESTERS OF ACETIC AND PROPIONIC ACIDS | E. I. DU PONT DE NEMOURS & CO. (US) | 1976-07-20 | — | — | US | disclosed |